SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-019338
Filing Date
2024-02-23
Accepted
2024-02-23 16:00:15
Documents
12
Period of Report
2024-02-20
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K rphm-20240220.htm   iXBRL 8-K 45887
  Complete submission text file 0000950170-24-019338.txt   171228

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rphm-20240220.xsd EX-101.SCH 32119
14 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20240220_htm.xml XML 4891
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 24670997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)